ARX 2001
Latest Information Update: 08 Feb 2005
At a glance
- Originator AlphaRx
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Immunological disorders
Most Recent Events
- 08 Feb 2005 Discontinued - Preclinical for Immunological disorders in Canada (unspecified route)
- 08 Nov 2001 New profile
- 08 Nov 2001 Preclinical development for Immunological disorders in Canada (Unknown route)